Skip to main content

Advertisement

SpringerLink
Log in

Laparoscopic low anterior resection with total mesorectal excision for rectal cancer

  • Letter
  • Published:
Surgical Endoscopy Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. Sartori CA, Dal Pozzo A, Franzato B, Balduino M, Sartori A, Baiocchi GL (2011) Laparoscopic total mesorectal excision for rectal cancer: experience of a single center with a series of 174 patients. Surg Endosc 25(2):508–514

    Article  PubMed  CAS  Google Scholar 

  2. Ziogas D, Roukos D (2008) Robotic surgery for rectal cancer: may it improve also survival? Surg Endosc 22(5):1405–1406

    Article  PubMed  Google Scholar 

  3. Katsios GC, Baltogiannis G, Roukos DH (2010) Laparoscopic surgery for gastric cancer: comparative-effectiveness research and future trends. Expert Rev Anticancer Ther 10(4):473–476

    Article  PubMed  Google Scholar 

  4. Liakakos T, Roukos D (2008) Laparoscopic gastrectomy: advances enable wide clinical application. Surg Endosc 22(6):1553–1555

    Article  PubMed  CAS  Google Scholar 

  5. Liakakos T, Roukos DH (2009) Randomized evidence for laparoscopic gastrectomy short-term quality of life improvement and challenges for improving long-term outcomes. Ann Surg 250(2):349–350

    Article  PubMed  Google Scholar 

  6. Roukos DH (2009) Laparoscopic gastrectomy and personal genomics: high-volume surgeons and predictive biomedicine may govern the future for resectable gastric cancer. Ann Surg 250:650–651

    Article  PubMed  Google Scholar 

  7. Liakakos T, Roukos DH (2008) Is there any long-term benefit in quality of life after laparoscopy-assisted distal gastrectomy for gastric cancer? Surg Endosc 22(5):1402–1404

    Article  PubMed  Google Scholar 

  8. Ziogas D, Polychronidis A, Kanellos I, Roukos D (2009) Laparoscopic colectomy survival benefit for colon cancer: is evidence from a randomized trial true? Ann Surg 249(4):695–696

    Article  PubMed  Google Scholar 

  9. Alberts SR, Sargent DJ, Smyrk TC et al (2010) Adjuvant mFOLFOX6 with or without cetuximab (Cmab) in KRAS wild-type (WT) patients (pts) with resected stage III colon cancer (CC): results from NCCTG Intergroup Phase III Trial N0147. J Clin Oncol 28(18 Suppl):Abstract CRA3507

  10. Green ED, Guyer MS; National Human Genome Research Institute (2011) Charting a course for genomic medicine from base pairs to bedside. Nature 470(7333):204–213

    Google Scholar 

  11. Katsios C, Roukos DH (2010) Individual genomes and personalized medicine: life diversity and complexity. Per Med 7(4):347–350

    Article  CAS  Google Scholar 

  12. Roukos DH, Katsios C, Liakakos T (2010) Genotype-phenotype map and molecular networks: a promising solution in overcoming colorectal cancer resistance to targeted treatment. Expert Rev Mol Diagn 10(5):541–545

    Article  PubMed  CAS  Google Scholar 

  13. Roukos DH (2010) Bionetworks-based personalized medicine versus comparative-effectiveness research or harmonization of both in cancer management? Expert Rev Mol Diagn 10(3):247–250

    Article  PubMed  Google Scholar 

  14. Katsios C, Ziogas DE, Roukos DH (2010) Colorectal cancer: cetuximab, KRAS, BRAF, PIK3CA mutations and beyond. Expert Rev Gastroenterol Hepatol 4(5):525–529

    Article  PubMed  CAS  Google Scholar 

  15. Roukos DH (2011) Translating epigenetics into an anticancer drug pipeline for solid tumors. Expert Rev Med Devices 8(4):409–413

    Article  PubMed  Google Scholar 

  16. Roukos DH, Kappas AM, Tsianos E (2002) Role of surgery in the prophylaxis of hereditary cancer syndromes. Ann Surg Oncol 9(7):607–609

    Article  PubMed  Google Scholar 

  17. Roukos DH, Agnanti NJ, Paraskevaidis E, Kappas AM (2002) Approaching the dilemma between prophylactic bilateral mastectomy or oophorectomy for breast and ovarian cancer prevention in carriers of BRCA1 or BRCA2 mutations. Ann Surg Oncol 9(10):941–943

    PubMed  Google Scholar 

  18. Roukos DH (2009) Isolated tumor cells in breast cancer. N Engl J Med 361:1994–1995; author reply 1995–1996

    Google Scholar 

  19. Roukos DH, Ziogas D (2010) From tumor size and HER2 status to systems oncology for very early breast cancer treatment. Expert Rev Anticancer Ther 10(2):123–128

    Article  PubMed  CAS  Google Scholar 

  20. Roukos DH, Kappas AM (2002) Targeting the optimal extent of lymph node dissection for gastric cancer. J Surg Oncol 81:59–62

    Article  PubMed  Google Scholar 

  21. Kappas AM, Fatouros M, Roukos DH (2004) Is it time to change surgical strategy for gastric cancer in the United States? Ann Surg Oncol 11:727–730

    Article  PubMed  Google Scholar 

  22. Roukos DH (1998) Extended lymphadenectomy in gastric cancer: when, for whom and why. Ann R Coll Surg Engl 80(1):16–24

    PubMed  CAS  Google Scholar 

  23. Roukos DH (2000) Extended (D2) lymph node dissection for gastric cancer: do patients benefit? Ann Surg Oncol 7:253–255

    Article  PubMed  CAS  Google Scholar 

  24. Roukos DH, Kappas AM, Agnantis NJ (2003) Perspectives and risks of breast-conservation therapy for breast cancer. Ann Surg Oncol 10:718–721

    Article  PubMed  Google Scholar 

  25. Briasoulis E, Fatouros M, Roukos DH (2007) Level I evidence in support of perioperative chemotherapy for operable gastric cancer: sufficient for wide clinical use? Ann Surg Oncol 14:2691–2695

    Article  Google Scholar 

  26. Roukos DH (2011) Chromatin: a key player in complex gene regulation and future cancer therapeutics. Epigenomics 3(4):395–399

    Article  PubMed  CAS  Google Scholar 

  27. Roukos DH (2011) Networks medicine: from reductionism to evidence of complex dynamic biomolecular interactions. Pharmacogenomics 12(5):695–698

    Article  PubMed  Google Scholar 

  28. Roukos DH (2011) Measurable evidence of miRNAs as regulators of cancer networks and therapeutic targets. Expert Rev Med Devices 8(2):123–126

    Article  PubMed  CAS  Google Scholar 

  29. Roukos DH (2011) Cancer genome explosion and systems biology: impact on surgical oncology? Ann Surg Oncol 18(1):12–15

    Article  PubMed  Google Scholar 

Download references

Disclosure

C. Hottenrott has no conflicts of interest or financial ties to disclose.

Author information

Authors and Affiliations

  1. Chirurgische Klinik, St. Elisabethenkrankenhaus, Ginnheimer Straße 3, 60487, Frankfurt am Main, Germany

    Christof Hottenrott

Authors
  1. Christof Hottenrott
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Christof Hottenrott.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Hottenrott, C. Laparoscopic low anterior resection with total mesorectal excision for rectal cancer. Surg Endosc 26, 578–579 (2012). https://doi.org/10.1007/s00464-011-1893-9

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00464-011-1893-9

Keywords

Search

Navigation